Literature DB >> 10606987

Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.

L Le Cleach1, S Delaire, L Boumsell, M Bagot, I Bourgault-Villada, A Bensussan, J C Roujeau.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare life-threatening adverse drug reaction characterized by a massive destruction of the epidermis. Immunohistological studies of skin biopsies of TEN showed infiltrates of predominantly CD8+ T lymphocytes even though other authors reported a prominent involvement of cells of the monocyte-macrophage lineage. The aim of this study was to characterize phenotypically and functionally the cells present in the cutaneous blister fluid of four patients with TEN. We first determined that lymphocytes were predominant in blister fluid obtained early, while monocytes/macrophages later became the most important population. We then showed that this lymphocyte population, mainly CD3+CD8+, corresponded to a peculiar cell subset as they expressed cutaneous leucocyte antigen, killer inhibitory receptors KIR/KAR and failed to express CD28 molecule. Functionally, we determined that blister T lymphocytes had a cytotoxic T lymphocyte (CTL)- and NK-like cytotoxicity. The role of this cytotoxic lymphocyte population present at the site of lesions during TEN remains to be understood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606987      PMCID: PMC1905549          DOI: 10.1046/j.1365-2249.2000.01119.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases.

Authors:  G Villada; J C Roujeau; T Clérici; I Bourgault; J Revuz
Journal:  Arch Dermatol       Date:  1992-01

Review 2.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

3.  Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.

Authors:  O Correia; L Delgado; J P Ramos; C Resende; J A Torrinha
Journal:  Arch Dermatol       Date:  1993-04

4.  Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics.

Authors:  M Hertl; J Geisel; C Boecker; H F Merk
Journal:  Br J Dermatol       Date:  1993-06       Impact factor: 9.302

5.  BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity.

Authors:  A Bensussan; E Gluckman; S el Marsafy; V Schiavon; I G Mansur; J Dausset; L Boumsell; E Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity.

Authors:  V David; J F Bourge; P Guglielmi; D Mathieu-Mahul; L Degos; A Bensussan
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.

Authors:  B Schnyder; K Frutig; D Mauri-Hellweg; A Limat; N Yawalkar; W J Pichler
Journal:  Clin Exp Allergy       Date:  1998-11       Impact factor: 5.018

8.  Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells.

Authors:  O J De Boer; E Horst; S T Pals; J D Bos; P K Das
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

9.  Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

Authors:  P Paquet; A Nikkels; J E Arrese; A Vanderkelen; G E Piérard
Journal:  Arch Dermatol       Date:  1994-05

10.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.

Authors:  V Litwin; J Gumperz; P Parham; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  25 in total

1.  Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.

Authors:  Simone Schmid; Petra C Kuechler; Markus Britschgi; Urs C Steiner; Nikhil Yawalkar; Alain Limat; Kurt Baltensperger; Lasse Braathen; Werner J Pichler
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption.

Authors:  Yoshiko Mizukawa; Yoshimi Yamazaki; Yuichi Teraki; Jun Hayakawa; Kazuhito Hayakawa; Hideko Nuriya; Michinori Kohara; Tetsuo Shiohara
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 3.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

Review 4.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

5.  The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions.

Authors:  Roni P Dodiuk-Gad; Wen-Hung Chung; Chih-Hsun Yang; Chun-Wei Lu; Rosaline Chung-Yee Hui; Neil H Shear
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

6.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 7.  T cells in drug allergy.

Authors:  Werner J Pichler
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

Review 8.  HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

Authors:  A J Redwood; R K Pavlos; K D White; E J Phillips
Journal:  HLA       Date:  2018-01       Impact factor: 4.513

Review 9.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

Review 10.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.